Biocorrx Company Profile (OTCMKTS:BICX)

About Biocorrx

Biocorrx logoBioCorRx, Inc., formerly Fresh Start Private Management, Inc., is a holding company. The Company is an addiction healthcare solutions company operating in Santa Ana, California. The Company, through its subsidiary, Fresh Start Private, Inc., provides alcoholism and opioid treatment program. It offers a medication-assisted treatment program that combines non-addictive medication coupled with psycho-social counseling. It also distributes and licenses the BioCorRx Recovery Program for alcoholism and opioid addiction treatment. The BioCorRxO Recovery Program consists of over two parts, which include an implant, administered by a licensed physician, of a compounded formulation of the drug, Naltrexone (implanted under the skin) (the Implant), which reduces alcohol cravings over a period of time, and a structured, intensive one on one counseling program developed by it. It offers BioCorRx Recovery Program in over 10 locations, including California, Arizona, Atlanta, Illinois and others.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: BICX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.04
  • 50 Day Moving Average: $0.0407
  • 200 Day Moving Average: $0.0336
  • 52-Week Range: $0.02 - $0.08
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $6.39M
  • Outstanding Shares: 166,094,000
  • Beta: -2.23
Additional Links:
Companies Related to Biocorrx:

Analyst Ratings

Consensus Ratings for Biocorrx (OTCMKTS:BICX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biocorrx (OTCMKTS:BICX)
No equities research coverage for this company has been tracked by


Earnings History for Biocorrx (OTCMKTS:BICX)
No earnings announcements for this company have been tracked by


Earnings Estimates for Biocorrx (OTCMKTS:BICX)
No earnings estimates for this company have been tracked by


Dividend History for Biocorrx (OTCMKTS:BICX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Biocorrx (OTCMKTS:BICX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2015Jorge Andrade JrDirectorSell125,000$0.06$7,500.00View SEC Filing  
2/26/2015Jorge Andrade JrDirectorSell245,000$0.05$12,250.00View SEC Filing  
2/23/2015Jorge Andrade JrDirectorSell215,000$0.06$12,900.00View SEC Filing  
2/17/2015Jorge Andrade JrDirectorSell90,000$0.08$7,200.00View SEC Filing  
2/10/2015Jorge Andrade JrDirectorSell60,000$0.09$5,400.00View SEC Filing  
10/28/2014Jorge Andrade JrDirectorSell25,000$0.09$2,250.00View SEC Filing  
10/13/2014Jorge Andrade JrDirectorSell80,000$0.09$7,200.00View SEC Filing  
10/7/2014Jorge Andrade JrDirectorSell40,000$0.11$4,400.00View SEC Filing  
10/1/2014Jorge Andrade JrDirectorSell30,000$0.13$3,900.00View SEC Filing  
9/29/2014Jorge Andrade JrDirectorSell170,000$0.10$17,000.00View SEC Filing  
9/22/2014Jorge Andrade JrDirectorSell130,000$0.10$13,000.00View SEC Filing  
9/15/2014Jorge Andrade JrDirectorSell90,000$0.10$9,000.00View SEC Filing  
9/8/2014Jorge Andrade JrDirectorSell95,000$0.11$10,450.00View SEC Filing  
8/22/2014Jorge Andrade JrDirectorSell100,000$0.13$13,000.00View SEC Filing  
8/14/2014Jorge Andrade JrDirectorSell300,000$0.14$42,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Biocorrx (OTCMKTS:BICX)
News Icon00 p.m. Eastern Time (OTCMKTS:BICX) - October 6 at 9:21 AM logoBioCorRx Inc. to Host Corporate Update Webinar on Wednesday, October 12th at 2:00 p.m. Eastern Time (OTCMKTS:BICX) - October 6 at 9:21 AM logoBioCorRx : to Present at the Singular Research 11th Annual Best of the Uncovereds Investment Conference September 22nd (OTCMKTS:BICX) - September 21 at 8:23 AM logoBioCorRx : Announces Update from First Joint Steering Committee Meeting for Injectable Naltrexone Product (OTCMKTS:BICX) - September 15 at 8:46 PM logoBioCorRx Inc. Announces Update From First Joint Steering Committee Meeting for Injectable Naltrexone Product (OTCMKTS:BICX) - September 15 at 12:44 PM logoBioCorRx Inc. Announces BioCorRx Pharmaceuticals Subsidiary; Forms Joint Steering Committee for Injectable Naltrexone Technology (OTCMKTS:BICX) - August 31 at 3:49 PM logoBioCorRx, Inc. Announces Agreement With Dr. David Gastfriend to Provide Strategic Initiative and Corporate Development Consulting (OTCMKTS:BICX) - August 17 at 12:00 PM
News IconBioCorRx Announces License Agreement with TheraKine Ltd. to Develop New Injectable Naltrexone Technology (OTCMKTS:BICX) - August 3 at 12:30 PM logoBIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (OTCMKTS:BICX) - August 3 at 12:30 PM logoBioCorRx Retains MZ Group as Investor Relations Advisor (OTCMKTS:BICX) - July 20 at 10:28 AM logoBioCorRx Launches R&D Initiative to Pursue FDA Approval for Naltrexone Implant (OTCMKTS:BICX) - July 14 at 8:00 AM logoAlpine Creek and BioCorRx Announce Major Investment Into BioCorRx (OTCMKTS:BICX) - June 20 at 2:01 PM logoBIOCORRX INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statemen (OTCMKTS:BICX) - May 20 at 5:05 PM logoBIOCORRX INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (OTCMKTS:BICX) - April 18 at 4:13 PM logoBIOCORRX INC. Files SEC form 10-K, Annual Report (OTCMKTS:BICX) - April 14 at 2:55 PM logoBioCorRx's Program to Help Beat Alcohol and Opioid Addiction Now in 20 Locations and Growing in Time for Alcohol Awareness Month (OTCMKTS:BICX) - April 4 at 8:24 AM


Biocorrx (OTCMKTS:BICX) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff